Matteo Droghetti

Urologist at IRCCS Azienda-Ospedaliero Universitaria di Bologna | SIU research Office - RWD section | PhD @unibo | Former ccERUS Clinical Fellow @NKI_nl

[European Urology Oncology @EurUrolOncol]

Read European Urology Oncology's latest article published online, by Lorenzo Bianchi et al.

Thank you for your contribution!

Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology—Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study

Explore the full study at: https://t.co/uVo021XiVF

@Lorenzo26232839
@drMDrog
@cal_Catanzaro
@MRoupret
@CaPsurvivorshop
@Ric_Campi
@jteoh_hk
@UroDocAsh
@Uroweb
@F_Montorsi
@Albert0Briganti
@ClaudiaKesch
@roodvdb
@riccardosciav6
@dr_rajwa

#UroOncology #ProstateCancer #MensHealth #eau #YAU #urologist

[Matteo Droghetti @drMDrog]

@VickersBiostats Still calling cancer something that not a single urologist wants to find in any biopsy specimen, and that comes only with problems for the patients first and also for healthcare costs linked to AS , still drives me crazy as Urologist

[Matteo Droghetti @drMDrog]

@VickersBiostats 100% agree. For PLND detractors The Gandaglia nomogram represents a good tool for opt-in or out from PLND in low volume HR PCa, sparing a significant number of unnecessary PLNDs while still chasing for significant pN+. We just need to use the right tools for decision making

[Matteo Droghetti @drMDrog]

@VickersBiostats @veerukasi @JAMA_current https://t.co/b2Oxs7EhWF microUS could possibly do that, still it remains quite operator dependent

[Lorenzo Bianchi @Lorenzo26232839]

Urology of Bologna involved in intensive presentations at EAU25 #Madrid @Uroweb @Unibo

[Matteo Droghetti @drMDrog]

Great to see published our efforts made during the period at @NKI_nl !
Kudos to @oktyzmn and all the team!!!

[Oktay Özman @oktyzmn]

Our paper from @NKI_nl showed PSMA PET/CT has a lymph node tumor burden-dependent #diagnosticability and consequently a strong independent #prognosticvalue for predicting #BCR after RP.
https://t.co/ogf7E4E2iH

@drMDrog @RobertoContieri

[riccardo schiavina @riccardoschiav6]

How important is knowledge of anatomy for the surgeons of the next gen? learn with the brightest young urologists and anatomists at the university of bologna

@Eugenio74446325
@aleantonellibs1
@minerviniandre
@agalfano
@pietropiazza
@paolo_delloglio
@GGandaglia
@RicBertolo
@andreamari08
@AngeloMottaran
@drMDrog

[Matteo Droghetti @drMDrog]

Great to see on @JUrology out results on oncological outcomes of sentinel node location in prostate cancer!
@NKI_nl @oktyzmn @hvdpoel @riccardoschiav6 @Eugenio74446325

Check out the PDF at https://t.co/NZ8NeZ99uz

[Matteo Droghetti @drMDrog]

@oktyzmn @so_uro @AcademicOner @ytanidir @halukakpinar @drcaydin @barbaroza @bulonal @DrHakanCakirUro @spongios @EAU_YAUProstate @alexmottrie @AlbertoBreda1 @Tilki_De @FraClaps @RobertoContieri Bx done transrect/transper or was it via TUR?

BTW unsure about what’s the best management in this case. RC given the mesenchymal nature of the tumor or RP?

[Evan Thomas MD/PhD @EvanThomas84]

Catching up some reading & good to see initial conclusions confirmed in longer term results, that adj RT after RP doesn’t improve FFDM or OS & ⬆️ toxicity compared to salvage.

There is slight curve sep at 10 years for FFDM with p = 0.09 but seems unlikely to become clinically relevant.

https://t.co/bMQKNovb6P

[Matteo Droghetti @drMDrog]

❓Could PSMA expression on PCa biopsy cores help select patients for PSMA pet?

▶️ Check out our recently published study

@FrontOncology @Eugenio74446325 @riccardoschiav6 @stefanofanti4 @Lorenzo26232839 @pietropiazza @AngeloMottaran

https://t.co/SCSwprPlGX

[riccardo schiavina @riccardoschiav6]

imagination goes beyond reality

[Matteo Droghetti @drMDrog]

@stefanofanti4 @Uroweb @Unibo Grazie mille prof!!

[Matteo Droghetti @drMDrog]

🏆Honored to receive this award for Best Oral Presentation, presenting our results of high risk PCa pts managed with intense obs+sRT. Thanks to everyone who supported this project, and to organizers and audience for this incredible honor 🙌
#EMUC23 @Uroweb @Unibo

[Matteo Droghetti @drMDrog]

@oktyzmn @Uroweb @Unibo Thank you my friend :)

[Lorenzo Bianchi @Lorenzo26232839]

Best abstract at EMUC23 EASY-1 project at @Unibo: with intensive surveillance almost 90% of high risk PCa can avoid aRT at 3 years! Congratulations to @drMDrog

[Matteo Droghetti @drMDrog]

@LambAlastair @treatyOfSharma @maggiesoxford @RuthMacPherson @uro_lopez @tomleslie21 @LabBryant @OxfordCancer @OxPCaBiol @PikaRoland @PromoteStudy @mercaderclaudia @Mutieraslan @AltanOmerElvis 54% pT3 and 58% HR PCa with just 10% LND? That’s a bit of a mismatch

[Marco Paciotti @Marco_Paciotti_]

1st Edition of the Italian #ESUBootCamp - It's a wrap!

A big thank you to all the trainees, the faculty, @UrowebESU @SIU_Italia @HUNIMED for making this a fantastic opportunity for young urology residents to gain hands-on training. #UrologyTraining

@NBuffi @tiago_urology

[Matteo Droghetti @drMDrog]

Very happy to be part of the first 🇮🇹 #ESU boot camp as a trainer today. Thanks to @HUNIMED , @SIU_Italia and @UrowebESU

[Matteo Droghetti @drMDrog]

@DrYukselUrun @EurUrolFocus @Uroweb @OncoAlert @AmerUrological @ASTRO_org @ESTRO_RT @piet_ost @DrSpratticus @OncoBellmunt @DrShariat @GGiannarini @AlbertoBossial @apolo_andrea @UroDocAsh @Prof_Nick_James @ProfSyedHussain But how do these findings get along with those from the ProtecT where no difference in OS was noted between RP and RT?